Medicinal Therapies for COVID-19 and its impact on Population Health

Information
information_group_1
Type of settings
On-line
Category of capacity building activity
Seminar/Webinar
COVID-19 related
Yes
PHIRI Activity
Yes
Activity schedule
Fixed date(s)
information_group_dates
Activity local date
-
Capacity Building Activity URL
https://www.phiri.eu/events/medicinal-therapies-covid-19-and-its-impact-populat…
information_group_2
GEO coverage
Europe
Language
English
Available in other languages
No
Target audience
Junior specialists;
Experts;
Public Health Sector;
Public Health Professionals;
Health Professionals;
Public Health Authorities

Agenda

  1. Welcome and Introduction - Petronille Bogaert (Sciensano)
  2. COVID-19 medicines: Hype and hope - Claudia Wild (EUNetHTA, Austrian Institute for HTA)
  3. COVID-19 medicines: from a payers’ perspective - Joël Daems (RIZIV/INAMI, TaskForce Vaccination and HTA TaskForce for COVID Medicines, Belgium)
  4. COVID-19 therapies vs. vaccination: the false debate Impact of medicinal therapies on COVID-19 vaccination - Natalia Pasternak-Taschner (Columbia University, University of Sao Paulo and Science Question Institute, Brazil)
  5. Discussion - Moderated by Claudia Habl, Austrian National Public Health Institute (GÖG)
Topics
Health systems » Health system performance » Quality » Vaccination coverage;
Health status » Morbidity/disability » Communicable diseases » Covid-19
Free keywords
Medicinal Therapies
organization_group
Leading organizer
Gesundheit Österreich GmbH
Contact

PHIRI.Austria@goeg.at

Austrian National Public Health Institute, Stubenring 6, 1010 Vienna

Updated on 04 April 2022